We are HomologyOur mission is focused on curing disease and transforming patients’ lives We are Homology We Are Homology Leadership Board of Directors Technology Platform AAVHSC Platform Gene Therapy Gene Editing GTx-mAb Publications and Presentations Pipeline Clinical Trials Overview Gene Editing Clinical Trial for PKU Gene Therapy Clinical Trial for MPS II Culture & Careers Investors Overview Stock Information Stock Quote & Chart Historical Price Lookup Stock Calculator News & Events News Releases Investor Calendar Presentations Financial Information SEC Filings Annual Reports Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Investor Resources Email Alerts Contact IR Leadership“Working at Homology to develop transformative life-changing therapies for patients with rare diseases with significant unmet need is a privilege. We know that every second counts for these patients, so we aim to work quickly and efficiently – but always with integrity and a focus on compliance, quality and safety.”Paul Alloway, Ph.D., J.D.President and Chief Operating Officer“Everyone we work with is someone we like to be with, in or outside of work, who motivate us, make us laugh, and genuinely care about one another. Together, we transform hope into help for rare diseases.”Melissa GelorminiSenior Vice President, Human Resources“It’s a pleasure working with my Homology colleagues who apply their own functional lens and the broader company perspective to work towards getting treatments to patients faster. I believe this focus is what has propelled our programs so quickly through development and into the clinic.”Charles Michaud, Jr C.P.AVice President, Finance, Corporate Controller & Treasurer